154 related articles for article (PubMed ID: 11530807)
21. [An elderly patient with myelodysplastic syndrome successfully treated with combination of granulocyte-colony stimulating factor and continuous-drip infusion of low-dose cytarabine and etoposide].
Yamada T; Tsurumi H; Hara T; Fukuno K; Goto H; Oyama M; Moriwaki H
Rinsho Ketsueki; 2000 Mar; 41(3):218-21. PubMed ID: 10774251
[TBL] [Abstract][Full Text] [Related]
22. Involvement of the NUP98 gene in a chromosomal translocation t(11;20)(p15;q11.2) in a patient with acute monocytic leukemia (FAB-M5b).
Kakazu N; Shinzato I; Arai Y; Gotoh S; Matsushita A; Ishikawa T; Nagai K; Takahashi T; Ohno T; Tsuchiya T; Ohki M; Abe T
Int J Hematol; 2001 Jul; 74(1):53-7. PubMed ID: 11530805
[TBL] [Abstract][Full Text] [Related]
23. Increasing aclarubicin dosage of the conventional CAG (low-dose cytarabine and aclarubicin in combination with granulocyte colony-stimulating factor) regimen is more efficacious as a salvage therapy than CAG for relapsed/refractory acute myeloid leukemia.
Qu Q; Liu L; Zhang Y; Li X; Wu D
Leuk Res; 2015 Dec; 39(12):1353-9. PubMed ID: 26432074
[TBL] [Abstract][Full Text] [Related]
24. [A case of therapy-related leukemia/myelodysplastic syndrome following treatment of refractory testicular germ cell tumor].
Takizawa A; Miura T; Fujinami K; Osada Y; Tanaka M; Maruta I
Nihon Hinyokika Gakkai Zasshi; 2005 Nov; 96(7):701-4. PubMed ID: 16363657
[TBL] [Abstract][Full Text] [Related]
25. [Refractory anemia showing excess of blasts (BAEB) that transformed into acute myelogenous leukemia (AML-M2) with a t (?8;20) chromosomal abnormality].
Maekawa T; Fujii H; Shizumi Y; Ebisui S; Horishi M; Suyama Y; Miyoshi M; Horiike S
Gan No Rinsho; 1988 Dec; 34(15):2109-13. PubMed ID: 3230641
[TBL] [Abstract][Full Text] [Related]
26. Acute erythroleukemia with t(3;5) accompanied by hepatocellular carcinoma.
Nakagawa H; Tanaka S; Takashima T; Shizumi Y; Nishigaki H; Horiike S; Taniwaki M; Misawa S; Kashima K; Hironaka T
Int J Hematol; 1991 Jun; 54(3):213-7. PubMed ID: 1660736
[TBL] [Abstract][Full Text] [Related]
27. [An adolescent case of myelodysplastic syndrome following aplastic anemia].
Yoshihara T; Morimoto A; Itoi T; Nakagawa M; Kawakatsu H; Todo S; Morioka Y; Imashuku S; Hayano T; Okamoto T
Rinsho Ketsueki; 1989 Jan; 30(1):78-83. PubMed ID: 2716203
[TBL] [Abstract][Full Text] [Related]
28. [Successful treatment with G-CSF and continuous infusion of low-dose cytarabine and etoposide for therapy-related acute myeloid leukemia developed during chemotherapy for malignant lymphoma].
Yamamoto K; Nagata K; Morita Y; Hamaguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):488-92. PubMed ID: 12134707
[TBL] [Abstract][Full Text] [Related]
29. Carcinoma in adenoma of the papilla of Vater.
Uchida Y; Tomonari K; Shibata O; Hadama T; Shirabe J; Matsumoto K; Yokoyama S
Jpn J Surg; 1986 Sep; 16(5):371-6. PubMed ID: 3795632
[TBL] [Abstract][Full Text] [Related]
30. [Clinical Efficacy of Decitabine Combined with CAG Regimen for Myelodysplastic Syndrome-RAEB and Refractory Acute Myeloid Leukemia].
Yang XL; Wu YM; Cao YB; Li XH; Xu LX; Liu ZY; Liu B; Yan B; Li SW; DA WM; Wu XX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Aug; 23(4):1056-61. PubMed ID: 26314446
[TBL] [Abstract][Full Text] [Related]
31. Prognostic value of clonal chromosomal abnormalities in patients with primary myelodysplastic syndromes.
Gyger M; Infante-Rivard C; D'Angelo G; Forest L; Lussier P
Am J Hematol; 1988 May; 28(1):13-20. PubMed ID: 3369432
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic criteria for hypocellular acute leukemia: a clinical entity distinct from overt acute leukemia and myelodysplastic syndrome.
Nagai K; Kohno T; Chen YX; Tsushima H; Mori H; Nakamura H; Jinnai I; Matsuo T; Kuriyama K; Tomonaga M; Bennett JM
Leuk Res; 1996 Jul; 20(7):563-74. PubMed ID: 8795690
[TBL] [Abstract][Full Text] [Related]
33. Decitabine priming prior to low-dose chemotherapy improves patient outcomes in myelodysplastic syndromes-RAEB: a retrospective analysis vs. chemotherapy alone.
Ye L; Ren Y; Zhou X; Mei C; Ma L; Ye X; Wei J; Xu W; Meng H; Qian W; Mai W; Lou Y; Xu G; Qian J; Lou Y; Luo Y; Xie L; Lin P; Hu C; Jin J; Tong H
J Cancer Res Clin Oncol; 2017 May; 143(5):873-882. PubMed ID: 28108816
[TBL] [Abstract][Full Text] [Related]
34. Myelodysplastic syndromes in childhood. Report of 21 patients from Italy and West Germany.
Creutzig U; Cantù-Rajnoldi A; Ritter J; Romitti L; Odenwald E; Conter V; Riehm H; Masera G
Am J Pediatr Hematol Oncol; 1987; 9(4):324-30. PubMed ID: 3439582
[TBL] [Abstract][Full Text] [Related]
35. Erythroleukemia: a need for a new definition.
Park S; Picard F; Dreyfus F
Leukemia; 2002 Aug; 16(8):1399-401. PubMed ID: 12145675
[TBL] [Abstract][Full Text] [Related]
36. Low-dose cytarabine and aclarubicin combined with granulocyte colony-stimulating factor for the treatment of relapsed or primary refractory acute lymphocytic leukemia: a retrospective study of 25 Chinese patients.
Xue SL; Cui HX; Zou JY; Xue MX; Tang XW; Zhang YM; Wu DP
Hematol Oncol; 2013 Dec; 31(4):206-12. PubMed ID: 23616245
[TBL] [Abstract][Full Text] [Related]
37. Phase II study of combination human recombinant GM-CSF with intermediate-dose cytarabine and mitoxantrone chemotherapy in patients with high-risk myelodysplastic syndromes (RAEB, RAEBT, and CMML): an Eastern Cooperative Oncology Group Study.
Bennett JM; Young MS; Liesveld JL; Paietta E; Miller KB; Lazarus HM; Marsh RD; Friedenberg WR; Saba HT; Hayes FA; Dewald GW; Hiddemann W; Rowe JM
Am J Hematol; 2001 Jan; 66(1):23-7. PubMed ID: 11426487
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological evolution and multilineage involvement in erythroleukemia: report of a case.
Cuneo A; Gretel Carli M; Piva N; Fagioli F; Vandenberghe E; Dal Cin P; Castoldi G; Van Den Berghe H
Haematologica; 1991; 76(3):235-7. PubMed ID: 1743594
[TBL] [Abstract][Full Text] [Related]
39. A specific cutaneous lesion revealing myelodysplastic syndrome.
Kajisawa C; Matsui C; Morohashi M
Eur J Dermatol; 1998; 8(7):517-8. PubMed ID: 9854168
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of high-dose cytarabine and aclarubicin in combination with G-CSF regimen compared to intermediate/high-dose cytarabine and standard-dose cytarabine induction regimen for non-remission acute myeloid leukemia.
Lei M; Liu L; Wang Z; Wu D
Indian J Cancer; 2019; 56(2):167-172. PubMed ID: 31062738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
